Canadian Liver Foundation partners with Canadian Nuclear Isotope Council to improve diagnosis and treatment of liver cancer across Canada

The CLF strives to improve prevention and quality of life for those living with liver disease by advocating for better screening, early diagnosis and access to treatment and patient care; we are very excited to join forces with the CNIC as it provides hope to those affected by liver disease, especially those with liver cancer, in the form of innovative treatments such as Transarterial Radioembolization (TARE).”   READ MORE